Long non-coding RNAs (lncRNAs) have been well-established to act as regulators and mediators 17 of development and cell fate specification programs. LncRNA Mrhl (meiotic recombination 18 hotspot locus) has been shown to act in a negative feedback loop with WNT signaling to regulate 19 male germ cell meiotic commitment. In our current study, we have addressed the role of Mrhl in 20 development and differentiation using mouse embryonic stem cells (mESCs) as our model 21 system of study. We found Mrhl to be a nuclear-localized, chromatin-bound lncRNA with 22 moderately stable expression in mESCs. Transcriptome analyses and loss-of-function phenotype 23 studies revealed dysregulation of developmental processes and lineage-specific genes along with 24 aberrance in specification of early lineages during differentiation of mESCs. Genome-wide 25 chromatin occupancy studies suggest regulation of chromatin architecture at key target loci 26 through triplex formation. Our studies thus reveal a role for lncRNA Mrhl in regulating 27 differentiation programs in mESCs in the context of appropriate cues through chromatin-28 mediated responses. 29
Introduction 32
Since their discovery, embryonic stem cells (ESCs) and their potential in regenerative medicine 33 have been widely established. They have been programmed to form cone cells for the treatment 34 of age-related macular degeneration (Zhou et al., 2015) , used for the treatment of spinal cord 35 injury patients (Shroff & Gupta, 2015) , differentiated into cardiomyocytes for cardiac tissue 36 injury repair (Shiba et al., 2012) or into insulin secreting β-cells for treating Type II diabetes 37 (Bruin et al., 2015; Salguero-Aranda et al., 2016) . Their self-renewal characteristics coupled with 38 their capacity to differentiate into cell types of origin pertaining to all the three germ layers make 39 them an attractive model system to study queries related to development (Evans & Kaufman, 40 1981; Martin, 1981) . This entails that the molecular pathways and players contributing to the 41 physiology of stem cells be thoroughly characterized to explore their therapeutic potential to the 42 fullest. In purview of the aforesaid, we have addressed the role of lncRNA Mrhl in mESCs to understand 99 it as a molecular player in development and differentiation. We demonstrate through 100 transcriptome studies that depletion of Mrhl in mESCs leads to dysregulation of 1143 genes with 101 major perturbation of developmental processes and genes including lineage-specific transcription 102 factors (TFs) and cell adhesion and receptor activity related genes. mESCs with stable 103 knockdown of Mrhl displayed aberrance in specification of ectoderm and mesoderm lineages 104 with no changes in the pluripotency status of the cells, consistent with our transcriptome data. 105
Genome-wide chromatin occupancy studies showed Mrhl to be associated with ~22,000 loci. To 106 decipher chromatin-mediated target gene regulation, we overlapped the two datasets and found 107 key developmental TFs such as RUNX2, POU3F2 and FOXP2 to be directly regulated by Mrhl 108 possibly through RNA-DNA-DNA triplex formation. Our study delineates lncRNA Mrhl as a 109 chromatin regulator of cellular differentiation and development genes in mESCs, probably acting 110 to maintain the cells in a more primed state readily responsive to appropriate differentiation cues. 111
112
Results 113
Mrhl is a nuclear-localized, chromatin bound moderately stable lncRNA in mESCs 114
We analyzed poly (A) RNA-Seq datasets from the ENCODE database and observed that Mrhl is 115 expressed predominantly in the embryonic stages of tissues of various lineages (Figure 1-116   supplementary figure 1 ). In the brain, heart and lung, Mrhl is expressed all throughout different 117 stages of embryos whereas its expression is almost nil in the postnatal stages. However, in the 118 liver and the kidney, Mrhl expression is down regulated but not completely abrogated in the 119 postnatal stages. From E8.5 onwards, the mouse embryo undergoes a surge of differentiation, 120 cell specification and organogenesis phenomena. Our data analysis suggested that Mrhl might 121 have a selective role to play in these processes in the context of mouse embryonic development. 122
To address this, we used mESCs as our model system of study. RNA FISH revealed Mrhl to be 123 expressed primarily in the nulcei of mESCs ( Figure 1A) . Biochemical fractionation further 124 validated Mrhl to be present in the nuclear fraction, specifically the chromatin fraction in mESCs 125 ( Figure 1B, C) . We next addressed if Mrhl was actually associated with the chromatin for which 126 we performed H3 ChIP followed by qPCR and observed significant enrichment of Mrhl in H3 127 bound chromatin (Figure 1D) . To further understand the functional relevance of Mrhl in mESCs, 128 we performed an assay for RNA half-life and we found Mrhl to display moderate stability with a 129 half-life of 2.73 hours (Figure 1E ). Our observations herewith prompted us to investigate further 130 the functional roles of Mrhl in mESCs. 131 132
Differentiation assay, knockdown and transcriptome analyses reveal Mrhl to regulate 133 development and differentiation circuits in mESCs 134
We next differentiated the mESCs into embryoid bodies and very interestingly observed that 135
Mrhl was preferentially up regulated at days 4 and 6 of embryoid body formation (Figure 2A) . 136
In perspective of the negative feedback regulation between Mrhl and WNT signaling in 137 spermatogonial progenitors and of WNT signaling contributing to mESC physiology (Atlasi et 138 al., 2013; Price et al., 2013; Sokol, 2011) , we questioned whether Mrhl would function through 139 similar mechanisms in this context as well. We performed shRNA mediated knockdown of Mrhl 140 in mESCs and scored for its levels using RNA FISH followed by the status of β-CATENIN 141 localization by IF. We observed that in cells where Mrhl was depleted with high efficiency, β-142 CATENIN was still localized at the membrane indicating non-activation of the WNT pathway 143 ( Figure 2B ). Furthermore, p68 IP revealed that Mrhl does not interact with p68 in mESCs 144 ( Figure 2C ). Keeping these observations in mind, we performed transient knockdown of Mrhl in 145 mESCs using four independent constructs, two of which (referred to as sh. 1 and sh. 4 146 henceforth) showed us an average down regulation of 50% ( Figure 2D ) and subjected the 147 scrambled (scr.) and sh.4 treated cells to analysis by RNA-Seq. A quick comparison of the 148 FPKM values for Mrhl obtained in our analysis versus those reported in the ENCODE database 149 as well as of scr. versus sh.4 displayed Mrhl to be a low abundant lncRNA and confirmed our 150 knockdown efficiency respectively (Figure 2-supplementary figure 2A ). Furthermore, we 151 observed that the expression of pluripotency factors OCT4 (OCT), SOX2 and NANOG were not 152 affected upon Mrhl knockdown in mESCs (Figure 2-supplementary figure 2B ). We obtained a 153 total of 1143 genes which were dysregulated in expression with 729 being down regulated and 154 414 being up regulated in expression ( Figure 2E ) and we refer to them as the differentially 155 expressed genes (DEG, Supplementary File 1). The DEG majorly belonged to the class of 156 protein-coding genes and transcription factors with an interesting proportion belonging to 157 lincRNAs and antisense RNAs as well. Gene ontology (GO) analysis revealed diverse molecular 158 functions such as binding (23.6%), catalytic activity (18.3%), receptor activity (8.8%) and signal 159 transducer activity (7.4%) and biological processes such as cellular processes (40.9%), biological 160 regulation (15.8%), metabolic process (25.7%), developmental process (11.7%) and multicellular 161 organismal process (10.7%) to be affected ( Figure 2F) . We next performed a GO enrichment 162 analysis with a p-value<0.05 to understand if one or more of the perturbed processes/pathways 163 were statistically over represented over the others and we found positive regulation of 164 developmental processes and positive regulation of multicellular organismal processes to be two 165 such enriched perturbed processes ( Figure 2G ). Other processes such as protein metabolic 166 processes, lipid metabolic processes, phosphate metabolic processes, protein modification 167 processes and MAPK cascade were also amongst the GO enriched list of processes. We then 168 performed Fisher's exact test in the PANTHER interface with a p-value<0.001 and obtained 169 several interesting GO categories to be further enriched and represented such as cell-cell 170 signaling, ion transport, synaptic transmission, response to endogenous stimuli, ectoderm 171 development, anion transport, cell-cell adhesion and neuromuscular synaptic transmission 172 (Supplementary Table 1 ). The category of developmental processes (GO:0032502, 173
Supplementary File 2) posed as the most interesting one since it has appeared in both the 174 enrichment analyses and possessed the maximum number of perturbed genes i.e., 60 with a 175 significant p-value of 6.44E-05. We examined the DEG belonging to this category and found that 176 they belonged to two broad groups of lineage-specific TFs and cell adhesion/receptor activity. 177
The former group comprised genes encoding factors involved in neuronal lineage, hematopoietic 178 and vascular lineage, cardiac lineage, skeletal lineage, mesodermal lineage and pancreatic 179 lineage ( Supplementary Table 2A ) whereas the latter group consisted of genes responsible for 180 such functions as migration, axon guidance, signaling, growth and differentiation, structural roles 181 and cellular proliferation amongst others ( Supplementary Table 2B ). From our assays and 182 analyses herewith, we conclude that Mrhl majorly acts to regulate differentiation and 183 development related genes and processes in mESCs. Also, we compared the DEG in Mrhl 184 knockdown conditions in mESCs and GC1-Spg spermatogonial progenitors and made two observations: firstly, the perturbed transcriptome is vastly different, emphasizing the context-186 dependent role of Mrhl and secondly, about 25 genes were in common between the two datasets, 187 suggesting some common target genes of regulation for Mrhl across developmental model 188 systems (Figure 2-supplementary figure 2C) . with Cytoscape ( Figure 3A) . We obtained nine such co-expression modules. We then 196 interrogated each of the modules for functional enrichment with GeneMania tool and observed 197 diverse functions to be co-regulated by these groups of genes such as ion channel and transporter 198 activities for clusters 4 and 5, nervous system functions for cluster 6, immune system processes 199 for cluster 7 and responses to xenobiotic stimuli for cluster 8. Clusters 2 and 3 had varied 200 functional enrichments whilst clusters 1 and 9 did not show any of such functional 201
representations. These analyses further support our earlier observations all of which suggest that 202 in mESCs, Mrhl acts to primarily modulate development and differentiation related processes. 203
We also performed a TF-TF interaction analysis to understand the potential cross-talk between 204 the dysregulated set of TFs ( figure 3A). A heat map was generated for delineating the potential TF network by scanning the 210 promoter sequence of each TF with the motif for each TF (Fig. 3B) . RUNX2 was obtained as a 211 potential master TF since it had the maximum number of motifs for binding across the promoters 212 of all the other TFs followed by ERG (Figure 3-supplementary figure 3B ). Based on this 213 logic, a simplified TF hierarchy was established using STRING wherein we observed RUNX2 to 214 be at the top of the hierarchy with RB1, ERG, FEV, SMAD9 and HEYL being in the first tier 215 cannot be ruled out. Thus, we report a novel TF network or hierarchy operating in mESCs in the 217 context of Mrhl. Furthermore, since all the TFs are involved in the specification of one of the 218 three lineages, the observations herewith further emphasize on Mrhl acting to control cell fate 219 specification and differentiation related circuits in mESCs. in expression during embryoid body differentiation, we subjected the knockdown and control 234 cells to differentiation by the formation of embryoid bodies. Interestingly, we observed that over 235 days 2 to 8 of differentiation, there was a marked aberrance in the specification of lineages, 236 specifically the ectoderm and mesoderm lineages (Figure 4E, F) . For the ectoderm lineage, there 237 appears to be premature specification in the knockdown cells at day 2 with subsequent loss in 238 maintenance of the lineage at days 6 and 8. The mesoderm lineage appears to be under-specified 239 from the beginning of differentiation with some expression of the marker T at day 6 in the 240 knockdown cells These observations imply that Mrhl is required in mESCs to undergo proper 241 specification of early lineages, majorly the ectoderm and mesoderm lineages, although it might 242 not have a specific role in mESCs per se in the absence of differentiation cues. 243 244
Mrhl regulates target loci in mESCs through chromatin-mediated regulation 245
In order to further delineate the mechanism by which Mrhl regulates differentiation and 246 development related genes and processes in mESCs, we performed genome-wide chromatin 247 occupancy studies through ChIRP-Seq since we have demonstrated Mrhl to be a chromatin 248 bound lncRNA in mESCs. We obtained a total of 21,997 raw peaks and after keeping a cutoff 249 value of 5-fold enrichment, we obtained 21,282 peaks (Figure 5A, Supplementary File 4) , 250 emphasizing the significant and widespread chromatin occupancy of Mrhl in mESCs. The peak 251 lengths and fold changes appear to be distributed equally across all the chromosomes (Figure 5-252   supplementary figure 5A, B ). An annotation of the enriched peaks showed us that diverse 253 regions including intronic, intergenic and promoter regions of genes as well as repeat elements 254 undergo physical association with Mrhl ( Figure 5B ). Next, we overlapped the peaks from Supplementary Table 3A) . have been widely established. We first performed a search for motifs for binding to target 276 chromatin loci by Mrhl which led to the identification of three distinct motifs with motif 1 being 277 present in 21.46%, motif 2 being present in 28.16% and motif 3 being present in 43.08% of the 278 total number of peaks. (Figure 5D and supplementary table 3B ). Next, we analyzed the 279 promoters of the aforementioned genes corresponding to the region where ChIRP-Seq peaks 280 were obtained for the presence of one or more of the three motifs by FIMO in MEME suite 281 followed by potential triplex formation at those sites using the Triplexator program. We observed 282 the presence of only one motif (motif 3) at the Mrhl occupied region in POU3F2, motifs 1, 2 and 283 3 in FOXP2 and again motif 3 in RUNX2 and HOXB7. Interestingly, triplex prediction revealed 284 triplex forming potential at two different sites in POU3F2, one lying within the motif sequence 285 whereas in FOXP2 and RUNX2, potential triplex forming sites were found immediately adjacent 286 to the motif sequences. HOXB7, however, did not show propensity for triplex formation within 287 the Mrhl occupied region (Figure 5E, Supplementary table 3C, Supplementary File 6) . In lieu 288 of these observations, we conclude that Mrhl regulates key lineage-specific TFs at the chromatin 289 possibly through triple helix formation to regulate differentiation of mESCs. Moreira, & Kaessmann, 2019). In our studies we have characterized lncRNA Mrhl and its 369 functional significance in mESC towards decoding its role in developments. We show Mrhl to 370 regulate downstream genes and processes involved in differentiation and lineage specification 371 that was reflected in our phenotype studies. A major finding of this study was its potential direct 372 chromatin mediated regulation of key TFs that mediate differentiation of stem cells into a 373 specific lineage. Overall, we establish lncRNA Mrhl to be a mediator of differentiation and cell 374 fate specification events in mESCs. FISH studies were Cy5 labelled locked nucleic acid probes procured from Exiqon (reported in 452 (Arun et al., 2012) ). Briefly, cells were grown on gelatin coated coverslips. EBs were fixed in 453 4% paraformaldehyde for 7-8 hours at 4°C followed by equilibration in 20% sucrose solution 454 overnight and embedded in tissue freezing medium (Leica). The embedded tissues were then 455 cryo-sectioned and collected on Superfrost slides (Fisher Scientific). For cells, a brief wash was 456 given with 1X PBS (phosphate buffered saline, pH 7.4) followed by fixation with 2% 457 formaldehyde for 10 minutes at room temperature. The cells were then washed with 1X PBS 458 three times for 1 minute each and permeabilization buffer (1X PBS, 0.5% Triton X-100) was 459 added for 5 minutes and incubated at 4°C. The permeabilization buffer was removed and cells 460 were washed briefly with 1X PBS for three times at room temperature. For tissue sections, 461 antigen retrieval was performed by boiling the sections in 0.01M citrate buffer (ph 6) for 10 462 minutes. The sections were allowed to cool, washed in distilled water three times for 5 minutes 463 each and then in 1X PBS for 5 minutes, each time with gentle shaking.
For FISH, samples were blocked in prehybridization buffer [3% BSA, 4X SSC (saline sodium 465 citrate, pH 7)] for 40 minutes at 50°C. Hybridization (Mrhl probes tagged with Cy5, final 466 concentration 95nM) was performed with prewarmed hybridization buffer (10% dextran sulphate 467 in 4X SSC) for 1 hour at 50°C. After hybridization, slides were washed four times for 6 minutes 468 each with wash buffer I (4X SSC, 0.1% Tween-20) at 50°C followed by two washes with wash 469 buffer II (2X SSC) for 6 minutes each at 50°C. The samples were then washed with wash buffer 470 III (1X SSC) once for 5 minutes at 50°C followed by one wash with 1X PBS at room 471 temperature. For tissue sections, all washes were performed as mentioned above with a time of 4 472 minutes for buffers I-III. 473
For IF, samples were blocked with IF blocking buffer (4% BSA, 1X PBS) for 1 hour at 4°C. 474
Primary antibody solution (2% BSA, 1X PBS) was prepared containing the appropriate dilution 475 of desired primary antibody and the samples were incubated in it for 12 hours at 4°C. Next day, 476 the samples were washed with IF wash buffer (0.2% BSA, 1X PBS) three times for 5 minutes 477 each with gentle shaking. The samples were incubated in secondary antibody for 45 minutes at 478 room temperature and washed with 1X PBS three times for 10 minutes each with gentle shaking. 479
The samples were finally mounted in mounting medium containing glycerol and DAPI. 480 481
Biochemical fractionation 482

Cell fractionation 483
Approximately 5-10 million cells were lysed using lysis buffer (0.8 M sucrose, 150 mM KCl, 5 484 mM MgCl 2 , 6 mM β-mercaptoethanol and 0.5% NP-40) supplemented with 75 units/ml RNAse 485 inhibitor (Thermo Fisher Scientific) and 1X mammalian protease inhibitor cocktail (Roche) 486 and centrifuged at 10,000 g for 5 minutes at 4 °C. The supernatant containing cytoplasmic 487 fraction was mixed with 3 volumes of TRIzol for RNA extraction or with Laemmli buffer for 488 western blotting as described later. The resultant pellet was washed twice with lysis buffer and 489 was subjected to RNA or protein extraction. 490
Sub-nuclear fractionation 491
Approximately 10 million cells were lysed with hypotonic lysis buffer (10 mM Tris-HCl ph 7.5, 492 10 mM NaCl, 3 mM MgCl 2 , 0.3% v/v NP-40 and 10% v/v/ glycerol) supplemented with RNAse 493 inhibitor and mammalian protease inhibitor cocktail and centrifuged at 1,000 g for 5 minutes at 4 494 °C. The supernatant comprising the cytoplasmic fraction was kept aside and the nuclear pellet 495 was washed twice with hypotonic lysis buffer. The nuclear pellet was then resuspended in 496 modified Wuarin-Schibler buffer (10 mM Tris-HCl pH 7.0, 4 mM EDTA, 300 mM NaCl, 1 M 497 urea and 1% NP-40) supplemented with RNAse inhibitor and mammalian protease inhibitor 498 cocktail and vortexed for 10 minutes. Nucleoplasmic and chromatin fractions were separated by 499 centrifugation at 1,000 g for 5 minutes at 4 °C. The chromatin pellet was resuspended in 500 sonication buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 3 mM MgCl 2 , 0.5 mM PMSF, 75 501 units/ml RNAse inhibitor) and sonicated for 10 minutes. The chromatin was then obtained as the 502 supernatant following centrifugation at 18,000 g for 10 minutes at 4 °C to remove all debris. The 503 resultant nucleoplasmic and chromatin fractions were then subjected to RNA or protein 504 extraction as described later. PMSF. The debris was removed by centrifugation at 15,000 g for 10 minutes at 4°C and the 514 supernatant nuclear fraction was collected. To 1 mg of the nuclear fraction containing proteins, 7 515 μg of either pre-immune serum or p68 antibody was added and incubated overnight at 4°C. Next 516 day, the fraction was incubated with protein A dynabeads for 3 hours at 4°C. The beads were 517 washed with wash buffer (20 mM Tris-HCl pH 7.4, 2 mM MgCl 2 , 10 mM KCL, 150 mM NaCl, 518 10% glycerol, 0.2% NP-40) supplemented with RNase inhibitor, mammalian protease inhibitor 519 cocktail and PMSF. Subsequently, the beads were washed twice with wash buffer (as above with 520 0.5% NP-40) and collected. The beads were then resuspended either in RNAiso Plus and 521 subjected to RNA isolation for qRT-PCR analysis or in Laemmli buffer and resolved on a 10% 522 SDS-PAGE gel for western blotting analysis as described later. 523
Chromatin IP 524
Chromatin IP (ChIP) was performed as per Cotney and Noonan's protocol (Cotney & Noonan, 525 2015) . Approximately 6-7 million cells were cross-linked with 1% formaldehyde for 10 minutes. 526
The reaction was quenched with 125mM glycine for 5 minutes and washed twice with ice-cold 527 1X PBS. Cells were lysed using hypotonic lysis buffer (10mM Tris ph 7.5, 10mM NaCl, 3mM 528 MgCl 2 , 0.3% NP-40 and 10% glycerol) supplemented with RNAse inhibitor and mammalian 529 protease inhibitor cocktail. Nuclei were pelleted at 1200g for 10 minutes at 4°C and resuspended 530 in nuclear lysis buffer (0.1% SDS, 0.5% Triton X-100, 20mM Tris pH 7.5 and 150mM NaCl) 531
RNAse inhibitor and mammalian protease inhibitor cocktail. Resuspended nuclei were then 532 sonicated (Biorupter, 25 cycles) and ~15 ug chromatin was incubated with either 4μg H3 533 antibody or pre-immune serum overnight at 4°C. Antibody bound chromatin was then pulled 534 down using protein A dynabeads (Thermo Fischer Scientific) for 3 hours at 4°C. The beads were 535 then washed sequentially with wash buffer I (nuclear lysis buffer), wash buffer II (nuclear lysis 536 buffer with 500mM NaCl) and wash buffer III (10mM Tris pH 8.0, 0.5% NP-40, 0.5% sodium 537 deoxycholate, 1mM EDTA), each supplemented with RNAse inhibitor and mammalian protease 538 inhibitor cocktail for 5 minutes each. The beads were then either processed directly for western 539 blotting or subjected to elution for 1 hour at 55°C in elution buffer (100mM NaCl, 10mM Tris 540 pH 7.5, 1mM EDTA, 0.5% SDS) supplemented with 100ug/ml proteinase K. The supernatant 541 was then subjected to reverse cross-linking by heating for 10 minutes at 95°C and then taken 542 forward for RNA isolation using TriZol (Ambion). Anti-sense (As) DNA probes with BiotinTEG at 3' end was designed using the online probe 547 designer at single-molecule FISH online designer. As-DNA probes were designed for both 548
LncRNA Mrhl and LacZ for selective retrieval of RNA target by ChIRP. Cells were grown to 549 confluency and ~80 million cells were harvested to perform ChIRP. Cells were cross linked with 550 1% glutaraldehyde to preserve RNA-Chromatin interactions and cell pellet was prepared. 551
Crosslinked cells were lysed to prepare cell lysate using freshly prepared lysis buffer (50 mM 552
Tris-Cl pH 7.0, 10 mM EDTA, 1 % SDS) supplemented with 1mM PMSF, 1X mammalian 553 protease inhibitor cocktail (PI) and superase-in. The suspension was divided into 400 μl aliquots 554 and subjected immediately to sonication. Sonication was continued until the cell lysate was no 555 longer turbid. When lysate turned clear, 5 μl lysate was transferred to a fresh eppendorf tube. 90 556 μl DNA Proteinase K (PK) buffer (100 mM NaCl, 10 mM Tris-Cl pH 7.0, 1 mM EDTA, 0.5 % 557 SDS) supplemented with 5 μl PK was added and incubated for 45 min at 55°C. DNA was 558 extracted with Diagenode microChIP DiaPure purification kit to check DNA size on 1% agarose 559 gel. If bulk of the DNA smear was 100-500 bp, sonication was assumed completed. Subsequent 560 morning biotinylated DNA probes were hybridized to RNA and bound chromatin was isolated. 561
For a typical ChIRP sample using 1 ml of lysate, 5% was kept aside for RNA input and DNA 562 input. Hybridization buffer (750 mM NaCl, 1 % SDS, 50 mM Tris-Cl pH 7.0, 1 mM EDTA, 15 563 % formamide) supplemented with 1mM PMSF, 1X PI and superase-in was added to each lysate 564 tube. 100 pmol of probe mix was added per 1 ml chromatin (1 μl of 100 pmol/μl probe per 1 ml 565 chromatin). This was incubated for 4 hrs at 37 °C with shaking. 100 μl C-1 magnetic beads were 566 used per 100 pmol of probes. Beads were resuspended in original volume of lysis buffer 567 supplemented with PMSF, PI and superase-in. After 4 hr hybridization reaction was completed, 568 60 μl beads were added to each tube and incubated at 37 °C for 30 min with shaking. The beads 569 were then washed for five times with wash buffer (2× SSC, 0.5 % SDS, 1 mM PMSF). At last 570 wash, the beads were resuspended well. 100 μl was set aside for RNA isolation and 900 μl for 571 DNA isolation. All tubes were placed on DynaMag-2 magnetic strip and last traces of wash 572 buffer removed. RNA was isolated for further qRT-PCR analysis. LacZ was used as a negative 573 control. DNA was isolated and sent for high throughput sequencing in duplicates. 574
575
RNA isolation and PCR 576
Total RNA was isolated from cells or tissues using TRIzol (Thermo Fisher Scientific) for RNA-577 sequencing and IP or using RNAiso Plus (Takara Bio) for analysis by qRT-PCR as per the 578 manufacturer's protocol. All RNA samples were subjected to DNase treatment (NEB) and about 579 1-3.5 μg of the RNA was taken for cDNA synthesis using oligodT primers (Thermo Fisher 580 Scientific), RevertAid reverse transcriptase (Thermo Fisher Scientific) and RNase inhibitor 581 (Takara Bio). The cDNA was diluted 1:1 with nuclease free water and subjected to qRT-PCR 582 using SyBr green mix (Takara) in real-time PCR machine (BioRad CFX96). All semi-583 quantitative PCR was performed in thermal cycler machine (BioRad, Tetrad2) using Taq 584 polymerase (Takara). 585 586 587
Systems analysis 589
RNA-Seq analysis 590
E14tg2a cells treated with scrambled or Mrhl shRNA (shRNA 4) were subjected to RNA 591 isolation and quality check. RNA samples were then subjected to library preparation in 592 duplicates and sequenced on Illumina Hi-Seq 2500 platform. mm10 Genome was downloaded 593 from GENCODE and indexed using Bowtie2-build with default parameters. Adapter ligation 594 was done using Trim Galore (v 0.4.4) and each of the raw Fastq files were passed through a 595 quality check using the FastQC. PCR duplicates were removed using the Samtools 1.3.1 with the 596 help of 'rmdup' option. Each of the raw files were then aligned to mm10 genome assembly using 597
TopHat with default parameters for paired-end sequencing as described in (Trapnell et al., 2012) . 598
After aligning, quantification of transcripts was performed using Cufflinks and then Cuffmerge 599 was used to create merged transcriptome annotation. Finally differentially expressed genes were 600 identified using Cuffdiff. The threshold for DE genes was log2 (fold change) >1.5 for up 601 regulated genes and log2 (fold change) <1.5 for down regulated genes. The DE genes were 602 analyzed further using R CummeRbund package. 603
GO enrichment analysis 604
Gene Ontology (GO) analysis was performed in PANTHER (Thomas et al., 2003) . Significant 605 enrichment test was performed with the set of differentially expressed genes in PANTHER and 606
Bonferroni correction method was applied to get the best result of significantly enriched 607 biological processes. 608
Fisher's exact test 609
Fisher's exact test was performed in PANTHER Gene Ontology (GO) where p-value significance 610 was calculated based on the ratio of obtained number of genes to the expected number of genes 611 (O/E) considering the total number of genes for the respective pathway in Mus musculus. 612
Cluster analysis 613
Hierarchical clustering method was performed using Cluster 3.0 (de Hoon, Imoto, Nolan, & 614 Miyano, 2004). Gene expression data (FPKM of all samples i.e, scrambled and shRNA treated) 615 was taken and log2 transformed. Low expressed (FPKM<0.05) and invariant genes were 616 removed. Then genes were centered and clustering was performed based on differential 617 expression pattern of genes and fold change. Genes were grouped in 9 clusters and visualized as
